309
Views
13
CrossRef citations to date
0
Altmetric
Hematology

Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT)

, , , , , ORCID Icon, , , , ORCID Icon, & ORCID Icon show all
Pages 945-951 | Received 18 Dec 2017, Accepted 29 Jan 2018, Published online: 15 Feb 2018

References

  • Carrocini GC, Zamaro PJ, Bonini-Domingos CR. What influences Hb fetal production in adulthood?. Revista brasileira de hematologia e hemoterapia 2011;33:231-6
  • Sankaran VG, Orkin SH. The switch from fetal to adult hemoglobin. Cold Spring Harb Perspect in Med 2013;3:a011643
  • Borgio JF, AbdulAzeez S, Al-Nafie AN, et al. A novel HBA2 gene conversion in cis or trans: “α12 allele” in a Saudi population. Blood Cells Molec Dis 2014;53:199-203
  • Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010;5:11
  • Old J, Traeger-Synodinos J, Galanello R, et al. Prevention of thalassaemias and other haemoglobin disorders. Thalassaemia Int Fed Publ 2005;2:113-16
  • Al-Suliman A. Prevalence of B-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia. Annals Saudi Med 2006;26:14
  • Akhtar MS, Qaw F, Borgio JF, et al. Spectrum of α-thalassemia mutations in transfusion-dependent β-thalassemia patients from the Eastern Province of Saudi Arabia. Hemoglobin 2013;37:65-73
  • Ministry of Health Portal [Internet]. Kingdom of Saudi Arabia: MoH; 2014. Available online at: https://www.moh.gov.sa/HealthAware-ness/healthDay/2014/Pages/HealthDay-2014-05-08.aspx. Accessed November 28, 2017
  • Borgio JF. Molecular nature of alpha-globin genes in the Saudi population. Saudi Med J 2015;36:1271
  • Borgio JF, AbdulAzeez S, Al-Muslami A, et al. KLF1 gene and borderline hemoglobin A2 in Saudi population. Arch Med Sci 2018;14(1):230-236
  • Al-Abdulkareem AA, Ballal SG. Consanguineous marriage in an urban area of Saudi Arabia: rates and adverse health effects on the offspring. J Commun Health 1998;23:75-83
  • Abuzenadah AM, Hussein IM, Damanhouri GA, et al. Molecular basis of β-thalassemia in the western province of Saudi Arabia: identification of rare β-thalassemia mutations. Hemoglobin 2011;35:346-57
  • Cao A, Galanello R. Beta-thalassemia. Genet Med 2010;12:61-76
  • Steinberg MH, Rodgers GP. HbA2: biology, clinical relevance and a possible target for ameliorating sickle cell disease. Br J Haematol 2015;170:781-7
  • Barrett AN, Saminathan R, Choolani M. Thalassaemia screening and confirmation of carriers in parents. Best Pract Res Clin Obstet Gynaecol 2017;39:27-40
  • Giambona A, Passarello C, Renda D, et al. The significance of the hemoglobin A 2 value in screening for hemoglobinopathies. Clin Biochem 2009;42:1786-96
  • Old J, Harteveld CL, Traeger-Synodinos J, et al. Haemoglobin pattern analysis. In: Old J, Harteveld CL, Traeger-Synodinos J, et al. Prevention of thalassaemias and other haemoglobin disorders: 2nd ed. Thalassaemia International Federation, Nicosia, Cyprus. 2012. 35-55
  • Moghaddam ZK, Bayat N, Valaei A, et al. Coinheritance of α- and β-thalassemia: challenges in prenatal diagnosis of thalassemia. Iran J Blood Canc 2012;2:81-4
  • Stephens AD, Angastiniotis M, Baysal E, et al. ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol 2012;34:1-3
  • Mohanty D, Colah RB, Gorakshakar AC, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Commun Genet 2013;4:33-42
  • Mosca A, Paleari R, Ivaldi G, et al. The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol 2009;62:13-17
  • Galanello R. Screening and diagnosis for haemoglobin disorders. In: Old J, Angastiniotis M, Eleftheriou A, et al. Prevention of thalassaemias and other haemoglobin disorders, 2nd ed. Thalassaemia International Federation, Nicosia, Cyprus 2013: 31-48
  • Borgio JF, AbdulAzeez S, Naserullah ZA, et al. Mutations in the β‐globin gene from a Saudi population: an update. Int J Lab Hematol 2016;38(2):e38-e40
  • Eshghi P, Rashidi A, Zadeh-Vakili A, et al. Hematological phenotype of the IVS-I-5 (G > C) β-thalassemia mutation and assessment of Iran’s national screening criteria. Hemoglobin 2008;32:440-5
  • Hariharan P, Colaco S, Colah R, et al. Delta globin gene variations leading to reduction in HbA2 levels. Int J Lab Hematol 2016;38:610-15
  • Tripathi N, Soni JP, Sharma PK, et al. Role of haemogram parameters and RBC indices in screening and diagnosis of beta-thalassemia trait in microcytic, hypochromic Indian children. Int J Hematol Disord 2015;2:43-6
  • Denic S, Agarwal MM, Al Dabbagh B, et al. Hemoglobin A 2 lowered by iron deficiency and α-thalassemia: should screening recommendation for β-thalassemia change? ISRN Hematol 2013;2013:858294
  • Ghosh A, Woo JS, Wan CW, et al. Evaluation of a prenatal screening procedure for β‐thalassaemia carriers in a Chinese population based on the mean corpuscular volume (MCV). Prenatal Diagn 1985;5:59-65
  • Passarello C, Giambona A, Cannata M, et al. Iron deficiency does not compromise the diagnosis of high HbA2 β thalassemia trait. Haematologica 2012;97:472-3
  • Verma S, Gupta R, Kudesia M, et al. Coexisting iron deficiency anemia and Beta thalassemia trait: effect of iron therapy on red cell parameters and hemoglobin subtypes. ISRN Hematol 2014;2014:293216
  • Verhovsek M, So CC, O’Shea T, et al. Is HbA2 level a reliable diagnostic measurement for β‐thalassemia trait in people with iron deficiency? Am J Hematol 2012;87:114-16
  • Moafi A, Valian S, Nikyar Z, et al. Prevalence of minor β-thalassemia based on RBC indices among final suspected individuals in premarital screening program referred to genetic laboratories. Int J Hematol-Oncol Stem Cell Res 2010;4:23-7
  • Karimi ME, Rasekhi AR. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. Haematologia 2002;32:129-33
  • Chan LC, Ma SK, Chan AY, et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? J Clin Pathol 2001;54:317-20
  • Ou Z, Li Q, Liu W, et al. Elevated hemoglobin A2 as a marker for β-thalassemia trait in pregnant women. Tohoku J Exp Med 2011;223:223-6
  • Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med 2013;3:a011775
  • Moi P, Paglietti E, Sanna A, et al. Delineation of the molecular basis of delta-and normal HbA2 beta-thalassemia. Blood 1988;72:530-3
  • Kattamis C, Metaxotou‐Mavromati A, Wood WG, et al. The heterogeneity of normal Hb A2‐β thalassaemia in Greece. Br J Haematol 1979;42:109-23
  • So CC, Chan AY, Luo HY, et al. Hb A2 Hong Kong—a novel δ-globin variant in a Chinese family masks the diagnosis of β-thalassemia trait. Hemoglobin 2011;35:162-5
  • Prasing W, Pornprasert S. Measurement of HbA2 by capillary electrophoresis for diagnosing β-thalassemia/HbE disease in patients with low HbF. Lab Med 2014;45:226-30
  • Pant L, Kalita D, Singh S, et al. Detection of abnormal hemoglobin variants by HPLC method: common problems with suggested solutions. Int Sch Res Notices 2014;2014:257805
  • Fonseca SF, Amorim T, Purificação A, et al. Hemoglobin A2 values in sickle cell disease patients quantified by high performance liquid chromatography and the influence of alpha thalassemia. Revista brasileira de hematologia e hemoterapia 2015;37:296-301
  • Higgins TN, Khajuria A, Mack M. Quantification of HbA2 in patients with and without β-thalassemia and in the presence of HbS, HbC, HbE, and HbD Punjab hemoglobin variants: comparison of two systems. Am J Clin Pathol 2009;131:357-62
  • Jameel T, Baig M, Ahmed I, et al. Differentiation of beta thalassemia trait from iron deficiency anemia by hematological indices. Pak J Med Sci 2017;33:665
  • Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Ann Saudi Med 2011;31:229
  • Saffi M, Howard N. Exploring the effectiveness of mandatory premarital screening and genetic counselling programmes for β-thalassaemia in the Middle East: a scoping review. Pub Health Genomics 2015;18:193-203
  • AlHamdan NA, AlMazrou YY, AlSwaidi FM, et al. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 2007;9:372-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.